Emcure plea to direct NPPA to review HIV drugs price junked by DoP Farhat Nasim3 Feb 2020 1:41 PM ISTNew Delhi: In a setback to drugmaker Emcure Pharmaceuticals, the Department of Pharmaceuticals (DoP) has rejected the company's petition seeking to...
GSK gets USFDA nod for HIV-1 drug branded as Dovato Farhat Nasim9 April 2019 9:20 AM ISTGSK already has two-drug regimen Juluca on the market, but only for the smaller market of HIV patients that have received prior treatment. Dovato is...
Laurus Labs gets USFDA nod to Hydroxychloroquine tablets for treating malaria Farhat Nasim12 March 2019 12:01 PM ISTHydroxychloroquine tablet is also used, usually with other medications, to treat certain auto-immune diseases (lupus, rheumatoid arthritis) when other...
FDA approves first two-drug HIV regimen from GSK Ruby Khatun Khatun24 Nov 2017 10:37 AM ISTNEW YORK: The U.S. Food and Drug Administration (FDA) on Tuesday approved the first two-drug regimen to treat HIV, the virus that causes AIDS, aimed...
New ARV drugs, early diagnosis key to beating AIDS epidemic: UNAIDS Ruby Khatun Khatun22 Nov 2017 10:15 AM ISTCAPE TOWN: Developing new antiretroviral (ARV) drugs and using technology for early diagnosis are among steps needed to sustain momentum in fighting...
